- Home
- RPID vs DERM Comparison
RPID vs DERM Comparison
Compare RPID & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- DERM
- Stock Information
- Founded
- RPID 2006
- DERM 2014
- Country
- RPID United States
- DERM United States
- Employees
- RPID N/A
- DERM N/A
- Industry
- RPID Medical Specialities
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- RPID Health Care
- DERM Health Care
- Exchange
- RPID Nasdaq
- DERM Nasdaq
- Market Cap
- RPID 138.9M
- DERM 165.6M
- IPO Year
- RPID 2021
- DERM 2021
- Fundamental
- Price
- RPID $3.78
- DERM $7.60
- Analyst Decision
- RPID Strong Buy
- DERM Strong Buy
- Analyst Count
- RPID 2
- DERM 2
- Target Price
- RPID $8.00
- DERM $10.50
- AVG Volume (30 Days)
- RPID 91.6K
- DERM 112.2K
- Earning Date
- RPID 08-08-2025
- DERM 08-11-2025
- Dividend Yield
- RPID N/A
- DERM N/A
- EPS Growth
- RPID N/A
- DERM N/A
- EPS
- RPID N/A
- DERM N/A
- Revenue
- RPID $29,645,000.00
- DERM $56,243,000.00
- Revenue This Year
- RPID $18.54
- DERM $28.99
- Revenue Next Year
- RPID $20.55
- DERM $52.61
- P/E Ratio
- RPID N/A
- DERM N/A
- Revenue Growth
- RPID 28.36
- DERM N/A
- 52 Week Low
- RPID $0.66
- DERM $3.54
- 52 Week High
- RPID $4.50
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- RPID 54.24
- DERM 58.83
- Support Level
- RPID $3.65
- DERM $7.45
- Resistance Level
- RPID $4.50
- DERM $7.92
- Average True Range (ATR)
- RPID 0.30
- DERM 0.41
- MACD
- RPID 0.03
- DERM 0.04
- Stochastic Oscillator
- RPID 47.45
- DERM 60.39
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.